
- Tissu
- Saphenous vein
- Maladie
- Normal saphenous vein endothelium (primary cells; non-tumorigenic)
- Site métastatique
- Not applicable (normal, non-tumorigenic primary cell)
- Synonymes
- HSaVEC, HSVEC, Human saphenous vein endothelial cells, provitro 1210121
Documents
Cellules endothéliales de la veine saphène humaine (HSVEC)
Primary cell · Référence du produit 300699
Venous endothelium for bypass graft research
Personnalisation / Recommandations
- Cellules endothéliales de la veine saphène humaine (HSVEC)Primary cell€1,220.00
01Informations générales
- Description
Primary Human Saphenous Vein Endothelial Cells (HSaVEC) are isolated from the saphenous vein and offer a venous endothelial model alongside HUVEC. They are used in research on atherosclerosis, leukocyte adhesion and the endothelial failure of coronary bypass vein grafts.
HSaVEC show the typical cobblestone morphology and express CD31 and VE-cadherin. As cells from adult vessels, they differ from fetal HUVEC: they are more sensitive to oxidized LDL, respond less strongly to cytokines and can present antigen to T cells, making them a closer model of adult venous endothelium.
- Tissu
- Saphenous vein
- Maladie
- Normal saphenous vein endothelium (primary cells; non-tumorigenic)
- Site métastatique
- Not applicable (normal, non-tumorigenic primary cell)
- Applications
- Adult endothelial model: ox-LDL, leukocyte adhesion, antigen presentation and tumor cell adhesion; Endothelial dysfunction in coronary bypass patients, screening of interventions; Mechanobiology: shear stress and arterial-level stretch in vein graft arterialization; Oxidative stress and mitophagy in vein graft failure; Insulin and IGF-1 receptor signaling in type 2 diabetes; Biomaterials: bioactive wound dressings for chronic wounds
- Synonymes
- HSaVEC
- HSVEC
- Human saphenous vein endothelial cells
- provitro 1210121
02Donateur
- Âge du donneur
- Lot-specific (see CoA)
- Origine ethnique
- Lot-specific (see CoA)
03Classification
- Organisme
- Humain
- Sexe
- Spécifique au lot
- Propriétés de croissance
- Adepte
- Statut OGM
- Sans OGM
- Informations détaillées sur le statut OGM
- No genetic modification; primary human endothelial cells isolated from saphenous vein tissue. Not transformed or immortalized.
- Niveau de biosécurité
- 1
04Caractéristiques
- Morphologie
- Cobblestone (endothelial)
- Type de cellule
- Primary endothelial cells
- Tumorigène
- No
- Temps de doublement
- approx. 24 hours (under optimal EGM-2/EBM-2 conditions, Marelli-Berg et al. 2004)
05Manipulation et culture
- Milieu de culture
- Endothelial Cell Growth Medium
- Atmosphère d'incubation
37°C, 5% CO2, saturated humidity.
- Compléments alimentaires
- EGM-2-MV BulletKit supplements: hEGF, VEGF, hFGF-B, IGF-1, hydrocortisone, ascorbic acid, heparin, and 5% FBS (pre-formulated in EGM-2; no additional serum needed). Gelatin-coat culture vessels before seeding.
- Réactif de dissociation
- Subculture reagents as recommended on the certificate of analysis
- Revêtement de flacons
- 0.1–0.2% gelatin coating required (incubate gelatin solution 30 min at 37°C, aspirate excess before seeding)
- Repiquage
Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.
- Rapport de fractionnement
- 1 to 3
- Densité de semis
- More than 6,000 cells/cm²
- Renouvellement des fluides
- 24 hours after seeding, then every 48 to 72 hours
- Récupération après le dégel
Post-thaw viability ≥ 70 % viable cells. More than 80 % confluence within the expected recovery period.
- Décongélation et mise en culture
Thaw the cryovial quickly in a 37 °C water bath, swirling gently. Just before the last ice has melted, move the vial to a laminar flow hood and decontaminate its outer surface.
Transfer the cell suspension into a 15 ml centrifuge tube, add 10 ml of Endothelial Cell Growth Medium and centrifuge at 250 × g for 5 minutes.
Remove the supernatant and resuspend the cell pellet in 10 ml of Endothelial Cell Growth Medium. Check cell number and viability.
Divide the suspension between two 25 cm² culture flasks (5 ml each). Using two flasks reduces the risk of losing all cells if a passage fails.
Incubate at 37 °C, 5 % CO₂ and saturated humidity, with the screw caps opened by half a turn for gas exchange.
Change the medium after 24 hours to remove unattached cells, then every 48 to 72 hours, using pre-warmed medium only.
Subculture the cells at about 75 % confluence. Denser cultures undergo irreversible contact inhibition and stop proliferating. Use the subculture reagents recommended on the certificate of analysis.
Recommended seeding density: more than 6,000 cells/cm².
06Contrôle qualité et cryoconservation
- Stérilité
Mycoplasma contamination is excluded by PCR.
To ensure there is no bacterial, fungal or yeast contamination, cultures are subjected to visual inspection.
- Milieu de congélation
- As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
- Conditions de stockage
For long-term preservation, store vials in liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable for up to one week only.
- Conditions de livraison
Cryopreserved primary cells are shipped on dry ice. On receipt, check the cryovial for damage and transfer it without delay to appropriate storage.
07Expression et sensibilité
- Antigènes de surface
- CD31 (PECAM-1); VE-cadherin (CD144); von Willebrand factor (vWF); eNOS; HLA-DR (inducible); ICAM-1 (inducible); VCAM-1 (inducible); E-selectin (inducible); UEA-I lectin binding
- Récepteurs exprimés
- VEGFR2 (KDR); VEGFR1; TIE-2; EGFR (low)
08Identifiants
- Référence
- Human saphenous vein endothelial cells (HSVEC) (Cytion catalog number 300699)
- Numéro d'identification fiscale NCBI
- 9606
- Cellosaurus
- Not assigned
09Aspects juridiques et sécurité
- Consignes de sécurité
- When planning to store a cryovial in liquid nitrogen for future thawing, it is mandatory to adhere to stringent safety measures. Appropriate protective gloves and clothing are essential, and the use of a face mask or safety goggles is required during the transfer of frozen samples to or from the liquid nitrogen tank. This is to mitigate the risk of injury from potential cryovial explosions upon removal, which can result in the projection of sharp fragments. Primary cells are of human origin, and no known test procedure can ensure the complete absence of infectious agents. Handle all products as potentially infectious.
- Garantie
At Cytion, we stand behind the quality and viability of our products. We guarantee that our cells will be viable at the start of culture for 60 days after shipment from our facilities. We assure that all materials conform to the specifications described in the Certificate of Analysis and/or Product Sheet.
For full details, please refer to our Warranty Statement.
- Un accord de transfert de matériel est requis
- Oui